- Home
- ARQT vs ACHR Comparison
ARQT vs ACHR Comparison
Compare ARQT & ACHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- ACHR
- Stock Information
- Founded
- ARQT 2016
- ACHR 2018
- Country
- ARQT United States
- ACHR United States
- Employees
- ARQT N/A
- ACHR N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- ACHR Aerospace
- Sector
- ARQT Health Care
- ACHR Industrials
- Exchange
- ARQT Nasdaq
- ACHR Nasdaq
- Market Cap
- ARQT 1.1B
- ACHR 1.3B
- IPO Year
- ARQT 2020
- ACHR N/A
- Fundamental
- Price
- ARQT $10.19
- ACHR $5.50
- Analyst Decision
- ARQT Strong Buy
- ACHR Buy
- Analyst Count
- ARQT 5
- ACHR 7
- Target Price
- ARQT $14.40
- ACHR $8.93
- AVG Volume (30 Days)
- ARQT 2.3M
- ACHR 21.6M
- Earning Date
- ARQT 11-06-2024
- ACHR 11-07-2024
- Dividend Yield
- ARQT N/A
- ACHR N/A
- EPS Growth
- ARQT N/A
- ACHR N/A
- EPS
- ARQT N/A
- ACHR N/A
- Revenue
- ARQT $138,708,000.00
- ACHR N/A
- Revenue This Year
- ARQT $208.32
- ACHR N/A
- Revenue Next Year
- ARQT $48.56
- ACHR $2,048.97
- P/E Ratio
- ARQT N/A
- ACHR N/A
- Revenue Growth
- ARQT 182.84
- ACHR N/A
- 52 Week Low
- ARQT $1.76
- ACHR $2.82
- 52 Week High
- ARQT $13.17
- ACHR $7.02
- Technical
- Relative Strength Index (RSI)
- ARQT 57.11
- ACHR 71.67
- Support Level
- ARQT $8.90
- ACHR $4.15
- Resistance Level
- ARQT $10.42
- ACHR $4.86
- Average True Range (ATR)
- ARQT 0.68
- ACHR 0.38
- MACD
- ARQT 0.06
- ACHR 0.13
- Stochastic Oscillator
- ARQT 61.90
- ACHR 92.82
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.